What are the recommended doses of Vitamin D and calcium supplementation for individuals using Depo-Provera (medroxyprogesterone acetate)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Women using Depo-Provera should take 1300 mg of calcium and 600 IU of vitamin D daily to support bone health, as recommended by the American College of Obstetricians and Gynecologists 1. This recommendation is based on the fact that Depo-Provera can reduce bone mineral density, particularly in the first 2-3 years of use.

Importance of Calcium and Vitamin D Supplementation

Calcium and vitamin D supplementation helps mitigate the effect of Depo-Provera on bone health by supporting bone density. The Society of Obstetricians and Gynaecologists of Canada (SOGC) recommends these supplements alongside weight-bearing exercise for all Depo-Provera users.

  • The daily intake of 1300 mg of calcium and 600 IU of vitamin D is recommended for individuals between 9 and 18 years old 1.
  • For individuals between 19 and 50 years old, the recommended daily intake is 1000 mg of calcium and 600 IU of vitamin D 1.

Considerations for Optimal Absorption

For optimal absorption, calcium supplements should be divided into doses of no more than 500 mg at a time, taken with food. Vitamin D can be taken at any time of day. Users should also be aware that bone density typically recovers after discontinuing Depo-Provera, and the contraceptive benefits of this method may outweigh the temporary bone density concerns for many women.

Monitoring Bone Health

Regular follow-up with a healthcare provider is recommended to monitor bone health if using Depo-Provera long-term. This allows for early detection of any potential issues and adjustment of supplementation as needed. By prioritizing bone health and following these recommendations, women using Depo-Provera can minimize the risk of bone density loss and maintain overall health.

From the Research

Vitamin D and Calcium Supplementation for Depo Provera Users

  • The Canadian guidelines for vitamin D and calcium supplementation in Depo Provera users are not explicitly stated in the provided studies. However, a study published in The Journal of family practice 2 recommends that women using Depo Provera take 1300 mg of calcium and 400 IU of vitamin D.

Bone Mineral Density and Depo Provera Use

  • Long-term use of Depo Provera has been associated with a decrease in bone mineral density (BMD) and an increased risk of osteoporosis 3.
  • A study published in the Journal of pediatric and adolescent gynecology 4 found that most subjects on Depo Provera had normal BMD at first measurement, but low spinal BMD was associated with longer Depo Provera use.
  • Another study published in the International journal of gynaecology and obstetrics 5 found that new users of Depo Provera experienced a 3.6% loss of lumbar spine BMD and a 2.1% loss of femoral neck BMD at 12 months.

Calcium and Vitamin D Metabolism

  • A study published in the Annals of internal medicine 6 found that continuous low-dose hormone replacement therapy with conjugated equine estrogen and oral medroxyprogesterone, combined with adequate calcium and vitamin D, provides a bone-sparing effect in elderly women.
  • The study published in the International journal of gynaecology and obstetrics 5 found that the Depo Provera group had higher phosphorus concentrations at 12 months compared to the IUD group.

Recommendations for Depo Provera Users

  • Based on the study published in The Journal of family practice 2, women using Depo Provera should consider taking 1300 mg of calcium and 400 IU of vitamin D to support bone health.
  • Additionally, Depo Provera users should be aware of the potential risk of decreased BMD and osteoporosis with long-term use, and discuss this risk with their healthcare provider 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.